Future potential targets of antibody-drug conjugates in breast cancer

Future potential targets of antibody-drug conjugates in breast cancer

Metastatic breast cancer (BC) remains an incurable disease. Besides endocrine and targeted agents, chemotherapy is still a relevant therapeutic option for this disease. Recently, antibody-drug conjugates (ADCs) have shown to overcome the lack of tumor specificity and systemic toxicity typically asso...

Full description

Bibliographic Details
Main Authors: Chiara Corti, Luca Boscolo Bielo, Ambra Carnevale Schianca, Beatrice Taurelli Salimbeni, Carmen Criscitiello, Giuseppe Curigliano
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Breast
Subjects:
Antibody-drug conjugate
Drug development
Early phase
Antigen
Biomarker
Breast cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S0960977623004241

Similar Items

Similar Items